Literature DB >> 23354174

Analysis of calcium homeostasis in fresh lymphocytes from patients with sporadic Alzheimer's disease or mild cognitive impairment.

Anna Jaworska1, Jaroslaw Dzbek, Maria Styczynska, Jacek Kuznicki.   

Abstract

Alzheimer's disease (AD) is the most widespread, age-related neurodegenerative disorder. Its two subtypes are sporadic AD (SAD) of unknown etiology and genetically encoded familial AD (FAD). The onset of AD is often preceded by mild cognitive impairment (MCI). Calcium dynamics were found to be dysregulated in FAD models, but little is known about the features of calcium dynamics in SAD. To explore calcium homeostasis during the early stages of SAD, we investigated store-operated calcium entry (SOCE) and inositol triphosphate receptor (IP3R)-mediated calcium release into the cytoplasm in unmodified B lymphocytes from MCI and SAD patients and compared them with non-demented subjects (NDS). Calcium levels in the endoplasmic reticulum and both the rising and falling SOCE slopes were very similar in all three groups. However, we found that SAD and MCI cells were more prone to IP3R activation than NDS cells, and increases in calcium levels in the cytoplasm were almost twice as frequent in SAD cells than in NDS cells. MCI cells and SAD cells exhibited an enhanced magnitude of calcium influx during SOCE. MCI cells but not SAD cells were characterized by higher basal cellular calcium levels than NDS cells. In summary, perturbed calcium homeostasis was observed in peripheral cells from MCI and SAD patients. Thus, lymphocytes obtained from MCI subjects may be promising in the early diagnosis of individuals who will eventually develop SAD. However, no conclusions are made regarding SAD due to the limited number patients. This article is part of a Special Issue entitled: 12th European Symposium on Calcium.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354174     DOI: 10.1016/j.bbamcr.2013.01.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Presenilin-1 Delta E9 Mutant Induces STIM1-Driven Store-Operated Calcium Channel Hyperactivation in Hippocampal Neurons.

Authors:  Maria Ryazantseva; Anna Goncharova; Kseniia Skobeleva; Maksim Erokhin; Axel Methner; Pavel Georgiev; Elena Kaznacheyeva
Journal:  Mol Neurobiol       Date:  2017-07-13       Impact factor: 5.590

Review 2.  Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime.

Authors:  MaryKate McBrayer; Ralph A Nixon
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

3.  Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models.

Authors:  Sarah M Neuner; Lynda A Wilmott; Brian R Hoffmann; Khyobeni Mozhui; Catherine C Kaczorowski
Journal:  Behav Brain Res       Date:  2016-06-02       Impact factor: 3.332

Review 4.  Telomere shortening in neurological disorders: an abundance of unanswered questions.

Authors:  Erez Eitan; Emmette R Hutchison; Mark P Mattson
Journal:  Trends Neurosci       Date:  2014-03-31       Impact factor: 13.837

5.  Identification of tetrahydrocarbazoles as novel multifactorial drug candidates for treatment of Alzheimer's disease.

Authors:  K Honarnejad; A Daschner; A P Gehring; A Szybinska; A Giese; J Kuznicki; F Bracher; J Herms
Journal:  Transl Psychiatry       Date:  2014-12-16       Impact factor: 6.222

Review 6.  T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.

Authors:  Anna Mietelska-Porowska; Urszula Wojda
Journal:  J Immunol Res       Date:  2017-02-15       Impact factor: 4.818

7.  Amyloid-beta disrupts calcium and redox homeostasis in brain endothelial cells.

Authors:  Ana Catarina R G Fonseca; Paula I Moreira; Catarina R Oliveira; Sandra M Cardoso; Paolo Pinton; Cláudia F Pereira
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

Review 8.  Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.

Authors:  Pei-Pei Guan; Long-Long Cao; Pu Wang
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease.

Authors:  Magdalena Czeredys; Joanna Gruszczynska-Biegala; Teresa Schacht; Axel Methner; Jacek Kuznicki
Journal:  Front Mol Neurosci       Date:  2013-11-25       Impact factor: 5.639

10.  Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's disease.

Authors:  Kamran Honarnejad; Alexander Daschner; Armin Giese; Andrea Zall; Boris Schmidt; Aleksandra Szybinska; Jacek Kuznicki; Jochen Herms
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.